Prevalence and Severity of Potential Drug–Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy

Polypharmacy (PP) is a common problem in modern medicine, especially known to affect patients with chronic diseases such as multiple sclerosis (MS). With an increasing number of drugs taken, the risk of potential drug–drug interactions (pDDIs) is rising. This study aims to assess the prevalence and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachmann, Paula, Frahm, Niklas, Debus, Jane Louisa, Mashhadiakbar, Pegah, Langhorst, Silvan Elias, Streckenbach, Barbara, Baldt, Julia, Heidler, Felicita, Hecker, Michael, Zettl, Uwe Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949310/
https://www.ncbi.nlm.nih.gov/pubmed/35335968
http://dx.doi.org/10.3390/pharmaceutics14030592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949310/
https://www.ncbi.nlm.nih.gov/pubmed/35335968
http://dx.doi.org/10.3390/pharmaceutics14030592

Ejemplares similares